MedPath

湖南醇健医药有限公司

Ownership
-
Established
2021-09-08
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Dexamethasone Sodium Phosphate Injection

Product Name
地塞米松磷酸钠注射液
Approval Number
国药准字H20253644
Approval Date
Mar 18, 2025
NMPA

Danazol Capsules

Product Name
达那唑胶囊
Approval Number
国药准字H19994122
Approval Date
Aug 30, 2021
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.